Authors
Loading...
Randomized trial demonstrates that tauroursodeoxycholic acid reduces glycemic and inflammatory markers in diabetic rats, suggesting therapeutic potential for diabetes management.
Mohamed et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: